AVITA Medical (RCEL) Accumulated Expenses (2019 - 2025)

AVITA Medical's Accumulated Expenses history runs 7 years deep, the most recent figure standing at $7.8 million for Q4 2025.

• Quarterly Accumulated Expenses fell 25.24% year-over-year to $7.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.8 million (down 25.24% YoY) and the FY2025 annual result came in at $7.8 million, down 25.24% from the prior year.
• Accumulated Expenses was $7.8 million for Q4 2025 at AVITA Medical, up from $5.8 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $10.5 million in Q4 2024 and bottomed at $2.5 million in Q1 2021.
• A 5-year average of $6.1 million and a median of $6.0 million in 2023 frame the typical range for Accumulated Expenses.
• Annual changes were most pronounced in 2024 — Accumulated Expenses jumped 58.34% — and 2025, when it sank 40.72%.
• AVITA Medical's Accumulated Expenses stood at $5.4 million in 2021, then climbed by 23.49% to $6.6 million in 2022, then rose by 20.37% to $8.0 million in 2023, then surged by 31.1% to $10.5 million in 2024, then declined by 25.24% to $7.8 million in 2025.
• Business Quant data shows RCEL's Accumulated Expenses at $7.8 million in Q4 2025, $5.8 million in Q3 2025, and $7.9 million in Q2 2025.